About
Associate Professor Jeremy Grummet is an accomplished academic urologist wirth Monash University who specialises in the diagnosis and treatment of prostate cancer. In addition to his private practice, he is also the Director of Urology at the Alfred Hospital (Bayside Health).
One of his significant contributions to the field of urology is the development and promotion of transperineal biopsy as a safer alternative to the traditional transrectal biopsy for prostate cancer diagnosis. This technique is now recommended as the standard of care in official clinical guidelines and is the most commonly used prostate biopsy method in Australia. A/Prof Grummet is a prominent figure in the global TREXIT movement, which aimed to eliminate the practice of transrectal biopsy by the end of 2022.
He is also the co-founder of MRI PRO, an innovative online training program designed to enhance the accuracy and reporting standards of prostate MRI worldwide. MRI PRO has successfully advanced its mission, with radiologists and urologists from over 90 countries viewing its prostate MRI cases and webinar videos.
A/Prof Grummet holds the distinction of being the first non-European Member of the European Association of Urology (EAU) Prostate Cancer Guidelines Panel. These guidelines are widely used in Europe and endorsed globally, including by the Urological Society of Australia and New Zealand (USANZ).
He has pioneered the new treatment of focal therapy for prostate cancer in Australia and serves as a Primary Investigator for both the LIBERATE and FIREFLY prospective clinical registries, which use focal therapy for single-focus intermediate-risk localised prostate cancer. This research, conducted in Australia, leverages accurate imaging to target treatment precisely, minimising side effects. Similar targeted treatment approaches have become the standard of care for other solid organ cancers like breast cancer.
Associate Professor Grummet currently focuses his research efforts toward focal therapy and prostate cancer diagnostics, including MRI and biopsy. He supervises PhD and Master of Surgery researchers in this field, exploring topics such as the risk of biopsy sepsis, diagnostic accuracy, the role of MRI-targeted biopsy, and PSMA PET scanning.
One of his significant contributions to the field of urology is the development and promotion of transperineal biopsy as a safer alternative to the traditional transrectal biopsy for prostate cancer diagnosis. This technique is now recommended as the standard of care in official clinical guidelines and is the most commonly used prostate biopsy method in Australia. A/Prof Grummet is a prominent figure in the global TREXIT movement, which aimed to eliminate the practice of transrectal biopsy by the end of 2022.
He is also the co-founder of MRI PRO, an innovative online training program designed to enhance the accuracy and reporting standards of prostate MRI worldwide. MRI PRO has successfully advanced its mission, with radiologists and urologists from over 90 countries viewing its prostate MRI cases and webinar videos.
A/Prof Grummet holds the distinction of being the first non-European Member of the European Association of Urology (EAU) Prostate Cancer Guidelines Panel. These guidelines are widely used in Europe and endorsed globally, including by the Urological Society of Australia and New Zealand (USANZ).
He has pioneered the new treatment of focal therapy for prostate cancer in Australia and serves as a Primary Investigator for both the LIBERATE and FIREFLY prospective clinical registries, which use focal therapy for single-focus intermediate-risk localised prostate cancer. This research, conducted in Australia, leverages accurate imaging to target treatment precisely, minimising side effects. Similar targeted treatment approaches have become the standard of care for other solid organ cancers like breast cancer.
Associate Professor Grummet currently focuses his research efforts toward focal therapy and prostate cancer diagnostics, including MRI and biopsy. He supervises PhD and Master of Surgery researchers in this field, exploring topics such as the risk of biopsy sepsis, diagnostic accuracy, the role of MRI-targeted biopsy, and PSMA PET scanning.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— A/Prof Jeremy Grummet
Education & training
-
2009–2015 MD · Medicine and Surgery
-
2015–2019 Residency · Urologia
-
2019–2020 Fellowship · Subspecialty training
Career & appointments
-
2019-09–2020-08 Junior consultant
Licenses & insurance
Medical licenses
AU — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Urologia
Malpractice insurance:
AmTrust Europe · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 308 |
| Annual physical exam | 99395 | 1,370 |
| Vaccination administration | 90471 | 2,082 |
| Minor procedure (skin) | 17110 | 333 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 60 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 90 min | in_clinic | 270.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 5 · i10: 13
-
Outcomes of Urologia in adults — a multi-centre cohort
DOI: 10.6048/euroclin.2025.0 · PMID: 32736273 · cited by 28
-
European registry analysis of Urologia outcomes
DOI: 10.3398/euroclin.2024.1 · PMID: 31891495 · cited by 190
Invited talks
- Practical updates in Urologia European Annual Congress (Urologia) · Vienna · 2024 · invited
- Single-centre experience in Urologia National Society Meeting · Melbourne · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Urologia — Melbourne · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Society memberships
- WONCA Europe — Family Doctors — Member · since 2020
- national college of family doctors — Member · since 2020
- European Union of Medical Specialists (UEMS) — Member · since 2020
Articles by this doctor
- Patient education Patient guide to Urologia
- Awareness When should you see a urologia?
For international patients
- Coordinator
- Patient liaison · jeremy.grummet@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Location
1 tagPatient reviews
636 verified reviews4.86
★★★★⯨
636 reviews
- Bedside Manner
- 4.9
- Knowledge
- 4.9
- Wait Time
- 4.6
- Staff Friendliness
- 4.9
- Ease Of Appointment
- 4.8
- Value For Money
- 4.8
- Would Recommend Pct
- 96.0
Share your experience — help other patients find the right doctor. Write a review →
Recent reviews
-
★★★★★ ✓ Verified Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verified Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verified Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
